Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Giaccone

Showing results (321-330 of 359) with videos related to

Pageof 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumorsC J van Groeningen, G J Peters, J H Schornagel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2004
Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumorsG Giaccone, J L González-Larriba, A T van Oosterom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitorsJ-C Soria, F A Shepherd, J-Y Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancerJ R Kroep, G Giaccone, D A Voorn, et al.
Cell Death & Disease|July 25, 2012
Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumorsI Petrini, P S Meltzer, P A Zucali, et al.
The Journal of Biological Chemistry|November 23, 2000
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117VF Tagliavini, P M Lievens, C Tranchant, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992)P Baas, A Ardizzoni, F Grossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupG Giaccone, T A Splinter, C Debruyne, et al.
Scientific Reports|November 17, 2017
Differential overexpression of SERPINA3 in human prion diseasesS Vanni, F Moda, M Zattoni, et al.
The American Journal of Pathology|January 1, 1996
beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's diseaseG Giaccone, B Pedrotti, A Migheli, et al.
Pageof 36

Showing results (321-330 of 359) with videos related to

Sort By:
Pageof 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumorsC J van Groeningen, G J Peters, J H Schornagel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2004
Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumorsG Giaccone, J L González-Larriba, A T van Oosterom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitorsJ-C Soria, F A Shepherd, J-Y Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancerJ R Kroep, G Giaccone, D A Voorn, et al.
Cell Death & Disease|July 25, 2012
Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumorsI Petrini, P S Meltzer, P A Zucali, et al.
The Journal of Biological Chemistry|November 23, 2000
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117VF Tagliavini, P M Lievens, C Tranchant, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992)P Baas, A Ardizzoni, F Grossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupG Giaccone, T A Splinter, C Debruyne, et al.
Scientific Reports|November 17, 2017
Differential overexpression of SERPINA3 in human prion diseasesS Vanni, F Moda, M Zattoni, et al.
The American Journal of Pathology|January 1, 1996
beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's diseaseG Giaccone, B Pedrotti, A Migheli, et al.
Pageof 36